The FDA approved an updated round of COVD-19 vaccines for the 2026-2027 respiratory disease season that target circulating SARS-CoV-2 viruses.The agency approved two messenger RNA-based vaccines manufactured by Moderna, according to the company:

FDA approves updated COVID-19 vaccines for 2026-'27 season, targeting XFG variant. Limited eligibility for adults 65+ and those with high-risk conditions.

The Food and Drug Administration has approved the latest version of Pfizer and BioNTech's COVID-19 vaccine, the companies announced Thursday.

Approvals come as the CDC's vaccine advisory panel remains in legal limbo

The approvals come as COVID-19 infections increased in most states this month.